Ward Clara, Caughey Aaron B
Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
Department of Obstetrics, Gynecology, and Reproductive Sciences, Oregon Health Sciences University, Portland, OR, USA.
J Matern Fetal Neonatal Med. 2022 Jan;35(1):155-160. doi: 10.1080/14767058.2020.1713744. Epub 2020 Mar 31.
To examine the risk of meconium aspiration syndrome (MAS) by the week of gestational age in pregnancies with meconium-stained amniotic fluid (MSAF).
This is a retrospective cohort study derived from term pregnancies at a single tertiary institution over an 18-year period. Outcomes analyzed included MAS, acidemia, and Apgar scores. Univariate analysis was performed using chi-square and multivariable logistic regression was used to adjust for potential confounders.
A total of 34,303 deliveries ≥37 weeks were included; 23.7% were complicated by MSAF. Of the total study cohort, 272 (0.7%) neonates were diagnosed with MAS; this represented 3% of all deliveries complicated by MSAF. In the presence of MSAF, the risk of MAS increased with gestational age, from 1.3% at 38 weeks to 4.8% at 42 weeks ( < .001). Similarly, the risk of acidemia increased from 3.0% at 38 weeks to 7.0% at 42 weeks ( < .001). These findings were also demonstrated in patients with MAS in the absence of MSAF. The risk for both MAS and acidemia in the presence of MSAF persisted after controlling for potential confounders (aOR 1.31 [95% CI 1.18-1.46] and 1.20 [95% CI 1.05-1.37], respectively).
In women with MSAF, as gestational age increases, the risk of meconium aspiration syndrome also increases. Other factors with late-term and post-term pregnancy besides the presence of meconium may contribute to the evolution of MAS.
探讨羊水胎粪污染(MSAF)妊娠中按孕周计算的胎粪吸入综合征(MAS)风险。
这是一项回顾性队列研究,来源于一所单一的三级医疗机构18年间的足月妊娠。分析的结局包括MAS、酸血症和阿氏评分。使用卡方进行单因素分析,并使用多变量逻辑回归来调整潜在的混杂因素。
共纳入34303例孕周≥37周的分娩;23.7%合并MSAF。在整个研究队列中,272例(0.7%)新生儿被诊断为MAS;这占所有合并MSAF分娩的3%。在存在MSAF的情况下,MAS的风险随孕周增加,从38周时的1.3%增至42周时的4.8%(P<0.001)。同样,酸血症的风险从38周时的3.0%增至42周时的7.0%(P<0.001)。在无MSAF的MAS患者中也观察到了这些结果。在控制潜在混杂因素后,存在MSAF时MAS和酸血症的风险仍然存在(调整后的优势比分别为1.31[95%可信区间1.18 - 1.46]和1.20[95%可信区间1.05 - 1.37])。
在合并MSAF的女性中,随着孕周增加,胎粪吸入综合征的风险也增加。除胎粪存在外,晚期和过期妊娠的其他因素可能导致MAS的进展。